“Pioneering spirit” since 1963 continues with new markets, new app/website, new insights and more for 2023 and beyond
SINGAPORE – Media OutReach – 24 May 2023 – MIMS Pte Ltd, Asia’s largest multi-channel provider of drug information, medical communications, events management, and marketing services, celebrates its 60th anniversary this year.
The issuer is solely responsible for the content of this announcement.
About MIMS: Empowering Healthcare Communities to Improve Patient Outcomes
MIMS is Asia’s largest multi-channel provider of drug information, medical communications, events management, marketing, and recruitment services. Established in 1963, our work empowers healthcare professionals to improve patient outcomes by facilitating knowledge exchange and better decision-making. Today, MIMS is present in 18 markets globally with over two million healthcare professional subscribers to our drug & resource portal, digital and print publications.
Combining healthcare communications expertise with our established networks and presence in the Asian healthcare community, we enable clients to engage their stakeholders in meaningful dialogue through a range of medical and marketing communications services.
We facilitate long-term placement of nurses, pharmacists and doctors across the globe to match the demands of healthcare institutions looking for high calibre practitioners.
MIMS has offices in the following global markets:
Singapore (headquarters), Australia, China, Germany, Hong Kong SAR, Indonesia, India, Ireland, Japan, Korea, Malaysia, Myanmar, New Zealand, Philippines, Taiwan, Thailand, UAE, Vietnam
Learn more at https://corporate.mims.com/ or follow us at https://www.linkedin.com/company/mims-pte-ltd/
